Ocular Therapeutix, Inc (OCUL) Insider Ownership

Historic Ownership Trends

Data spanning the past 90 days through December 12, 2025 reveals that Ocular Therapeutix's three principal insider shareholders consist of Director Pravin Dugel (3.46Mn shares), Chief Strategy Officer Sanjay Nayak (277.86K shares), Chief Scientific Officer Jeffrey S. Heier (245.94K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Road Llc Summer 8,591,401 27 Feb, 2024
Pravin Dugel 3,458,075 26 Nov, 2025
Antony C. Mattessich President And CEO 595,201 06 Feb, 2024
Michael H. Goldstein President And Ophthalmology & Cmo 313,335 07 Feb, 2022
Donald Notman 308,807 04 Sep, 2025
Sanjay Nayak Chief Strategy Officer 277,860 26 Nov, 2025
Nadia Waheed Chief Medical Officer 247,168 14 Aug, 2025
Jeffrey S. Heier Chief Scientific Officer 245,940 26 Nov, 2025
Peter Kaiser Chief Development Officer 191,433 26 Nov, 2025
Namrata Saroj Chief Business Officer 174,135 07 Nov, 2025
Philip C. Strassburger General Counsel 161,493 06 Feb, 2024
Rabia Gurses Ozden Chief Medical Officer 153,054 06 Feb, 2024
Richard L Md Lindstrom 143,145 13 Jun, 2025
Christopher G White Chief Business Officer 123,689 06 Feb, 2024
Todd Anderman Chief Legal Officer 87,568 10 Oct, 2025
Charles M Warden 86,464 13 Jun, 2025
Leslie J. Williams 51,433 13 Jun, 2025
Adrienne L Graves 50,000 13 Jun, 2025
Seung Suh Hong 46,933 13 Jun, 2025
Merilee Raines 46,933 13 Jun, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
24 Nov, 2025 Jeffrey S. Heier Common Stock D 3,469 $12.04 245,940 D S
24 Nov, 2025 Sanjay Nayak Common Stock D 1,878 $12.04 277,860 D S
24 Nov, 2025 Peter Kaiser Common Stock D 3,007 $12.02 191,433 D S
24 Nov, 2025 Pravin Dugel Common Stock D 19,530 $12.04 3,157,960 D S
26 Nov, 2025 Pravin Dugel Common Stock D 49,754 $0.00 0 I G
26 Nov, 2025 Pravin Dugel Common Stock A 49,754 $0.00 300,115 I G
05 Nov, 2025 Namrata Saroj Common Stock D 25,865 $10.74 174,135 D S
08 Oct, 2025 Todd Anderman Common Stock D 11,132 $12.34 87,568 D S
02 Oct, 2025 Peter Kaiser Common Stock D 9,653 $11.03 194,440 D S
02 Oct, 2025 Jeffrey S. Heier Common Stock D 10,502 $11.04 249,409 D S
09 Sep, 2025 Pravin Dugel Common Stock D 49,754 $0.00 3,177,490 D G
09 Sep, 2025 Pravin Dugel Common Stock A 49,754 $0.00 49,754 I G
02 Sep, 2025 Donald Notman Common Stock D 1,066 $12.43 308,807 D S
02 Sep, 2025 Donald Notman - - 308,807 D
25 Aug, 2025 Sanjay Nayak Common Stock D 1,885 $12.04 279,738 D S
25 Aug, 2025 Jeffrey S. Heier Common Stock D 3,063 $12.04 259,911 D S
25 Aug, 2025 Peter Kaiser Common Stock D 3,011 $12.04 204,093 D S
25 Aug, 2025 Pravin Dugel Common Stock D 21,494 $12.04 3,227,244 D S
12 Aug, 2025 Nadia Waheed Common Stock A 40,363 $0.00 247,168 D A
12 Aug, 2025 Nadia Waheed - - 247,168 D